DE eng

Search in the Catalogues and Directories

Page: 1 2
Hits 1 – 20 of 35

1
The laryngoscope and 19th century British understanding of laryngeal movements
Lorch, Marjorie; Whurr, R.. - : Taylor and Francis, 2019
BASE
Show details
2
Morell Mackenzie’s contribution to the description of spasmodic dysphonia
Lorch, Marjorie; Whurr, R.. - : Sage, 2016
BASE
Show details
3
Review of differential diagnosis and management of spasmodic dysphonia
Whurr, R.; Lorch, Marjorie. - : Lippincott, Williams & Wilkins, 2016
BASE
Show details
4
Tracing Spasmodic Dysphonia: the source of Ludwig Traube’s priority
Lorch, Marjorie; Whurr, R.. - : Sage, 2016
BASE
Show details
5
Differential effect of linguistic and non-linguistic pen-holding tasks on motor cortex excitability
In: EXP BRAIN RES , 191 (2) 237 - 246. (2008) (2008)
BASE
Show details
6
Changes in corticospinal motor excitability induced by non-motor linguistic tasks
In: EXP BRAIN RES , 154 (2) 218 - 225. (2004) (2004)
BASE
Show details
7
Cross-linguistic study of vocal pathology: perceptual features of spasmodic dysphonia in French-speaking subjects
Whurr, R.; Lorch, Marjorie. - : Taylor and Francis, 2003
BASE
Show details
8
Plasticity of motor cortex excitability induced by rehabilitation therapy for writing
In: NEUROLOGY , 61 (7) 977 - 980. (2003) (2003)
BASE
Show details
9
Perceptual aspects of spasmodic dysphonia across different languages
BASE
Show details
10
Systematic review of paramedical therapies for Parkinson's disease
In: MOVEMENT DISORD , 17 (5) 984 - 991. (2002) (2002)
BASE
Show details
11
Speech and language therapy for dysarthria in Parkinson's disease.
In: Cochrane Database Syst Rev (2) CD002812-. (2001) (2001)
Abstract: BACKGROUND: Dysarthria is a common manifestation of Parkinson's disease which increases in frequency and intensity with the progress of the disease (Streifler 1984). Up to 20% of Parkinsonian patients are referred for speech and language therapy (S & L T), its aim being to improve the intelligibility of the patient's speech. OBJECTIVES: To compare the efficacy of speech and language therapy versus placebo or no interventions in patients with Parkinson's disease. SEARCH STRATEGY: Relevant trials were identified by electronic searches of MEDLINE, EMBASE, CINAHL, ISI-SCI, AMED, MANTIS, REHABDATA, REHADAT, GEROLIT, Pascal, LILACS, MedCarib, JICST-EPlus, AIM, IMEMR, SIGLE, ISI-ISTP, DISSABS, Conference Papers Index, Aslib Index to Theses, the Cochrane Controlled Trials Register, the CentreWatch Clinical Trials listing service, the metaRegister of Controlled Trials, ClinicalTrials.gov, CRISP, PEDro, NIDRR and NRR; and examination of the reference lists of identified studies and other reviews. SELECTION CRITERIA: Only randomised controlled trials (RCT) were included. DATA COLLECTION AND ANALYSIS: Data were abstracted independently by KD and RW and differences settled by discussion. MAIN RESULTS: Three randomised controlled trials were found comparing speech and language therapy with placebo for speech disorders in Parkinson's disease. A total of 63 patients were examined. The loudness of the patients' voices were increased by between 7-18%, depending on the speaking task being performed. It is likely that this is a clinically significant improvement. After six months the degree of improvement was reduced but was still statistically significant. Overall measures of dysarthria were measured in two trials and also improved. The clinical significance of these improvements was less clear cut as intelligibility of speech was not measured in any of these studies. REVIEWER'S CONCLUSIONS: Considering the small number of patients examined, the methodological flaws in many of the studies, and the possibility of publication bias, there is insufficient evidence to support or refute the efficacy of speech and language therapy for dysarthria in Parkinson's disease. A Delphi-style survey is needed to develop a consensus as to what is 'standard' S< for dysarthria in Parkinson's disease. Then a large well designed placebo-controlled RCT is needed to demonstrate speech and language therapy's effectiveness for dysarthria in Parkinson's disease. The trial should conform to CONSORT guidelines. Outcome measures with particular relevance to patients should be chosen and the patients followed for at least 6 months to determine the duration of any improvement.
Keyword: Dysarthria; Humans; Language Therapy; Parkinson Disease; Randomized Controlled Trials as Topic; Speech Therapy
URL: http://discovery.ucl.ac.uk/26315/
BASE
Hide details
12
A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease.
In: Cochrane Database Syst Rev (2) CD002814-. (2001) (2001)
BASE
Show details
13
The nature of speech and language impairment in adults with neurofibromatosis 1
In: Journal of neurolinguistics. - Orlando, Fla. : Elsevier 12 (1999) 3, 157-166
OLC Linguistik
Show details
14
The incidence and nature of dysphagia following botulinum toxin injections for torticollis
Whurr, R.; Bhatia, K.P.; Marsarei, A.. - : Delmar Cengage Learning, 1999
BASE
Show details
15
Acquired disorders of language (aphasia): evaluation of effectiveness of intervention
Lorch, Marjorie; Whurr, R.. - : Elsevier, 1999
BASE
Show details
16
The nature of speech and language impairment in adults with neurofibromatosis
Golding, J.; Lorch, Marjorie; Whurr, R.. - : Elsevier, 1999
BASE
Show details
17
Beyond the single word: Intervention in acquired disorders - An investigation into the drawing skills of aphasic adults
In: International journal of language & communication disorders. - Oxford : Wiley-Blackwell 33 (1998), 218-225
OLC Linguistik
Show details
18
Assessment and efficacy in acquired disorders - Treatment for aphasia following stroke: Evidence for effectiveness
In: International journal of language & communication disorders. - Oxford : Wiley-Blackwell 33 (1998), 158-161
OLC Linguistik
Show details
19
Voice: Imaging and intervention - Meta-analysis of botulinum toxin treatment of spasmodic dysphonia: A review of 22 studies
In: International journal of language & communication disorders. - Oxford : Wiley-Blackwell 33 (1998), 327-331
OLC Linguistik
Show details
20
Designing assessments - Children's Acquired Aphasia Screening Test
In: International journal of language & communication disorders. - Oxford : Wiley-Blackwell 33 (1998), 343-344
OLC Linguistik
Show details

Page: 1 2

Catalogues
0
0
5
0
0
0
0
Bibliographies
0
0
0
0
0
0
0
0
5
Linked Open Data catalogues
0
Online resources
0
0
0
0
Open access documents
25
0
0
0
0
© 2013 - 2024 Lin|gu|is|tik | Imprint | Privacy Policy | Datenschutzeinstellungen ändern